Harvard Business Review

OCTOBER 25, 2018

These firms make up two thirds of global corporate pretax earnings (EBTDA) and revenues. The bottom 10% destroy roughly as much economic value as the superstar firms create. But this is also mirrored by firms in the bottom 10%, which account for 1.5 Superstar firms create 1.6 times more economic loss today than 20 years ago.

Industry 10

Industry Company GDP Bottom-up 10

Harvard Business Review

NOVEMBER 29, 2018

In this article, I’d like to share the insights we’ve gleaned from the model’s first full year of operation, which hopefully organizations in health care and many other industries will find useful. The information that escalates up falls into two categories: Issues that cannot be resolved at a given tier.

Health Care 9

Health Care System Metrics Report 9

Harvard Business Review

NOVEMBER 15, 2018

hospitals and health systems experienced an average 39% reduction in their operating margins from 2015 to 2017. Cost reduction requires an honest and thorough reassessment of everything the health system does and ultimately, a change in the organization’s operating culture. PM Images/Getty Images. ” Clearly, more is needed.

Cost 9

Cost System Management Franchising 9

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. As a group, the largest U.S. In some instances, the end results were firm closures and lost jobs.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

JANUARY 24, 2012

Nine years ago, when I launched The Energy Project during an economic boom, it was nearly impossible to find senior leaders open to the idea that demand was exceeding people's capacity, and that it was critical to the bottom line to teach employees new ways to manage their energy more skillfully.

Meyer 14

Meyer Goleman Emotional Intelligence Pharmaceuticals 14

Harvard Business Review

DECEMBER 5, 2016

We believed that if the Library was to be truly nimble, senior leaders couldn’t unilaterally come up with a plan. The conversation would be neither bottom-up nor top down. These diverse groups of volunteer employees work across organizational boundaries and outside of their regular operational duties.

Library 8

Library Strategy Reference Bottom-up 8

Harvard Business Review

JANUARY 31, 2013

We see advances in materials, processes, and information technology that will make possible entirely new kinds of products and can radically alter how manufacturers operate. Pharmaceutical companies are mastering bio-engineering techniques that will help develop personalized medicines. The Dynamics of Global Manufacturing Are Shifting.

Globalization 8

Globalization Supply Chain Pharmaceuticals McKinsey 8